PINK:OTLC

Oncotelic Therapeutics Stock Forecast

etoro logo Buy OTLC
*Your capital is at risk
$0.0341
-0.0047 (-12.00%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of OTLC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OTLC to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Oncotelic Therapeutics, Inc. stock price on Monday moving 26.49% between high and low
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 25, 2026 Loss -20.16%

The Oncotelic Therapeutics, Inc. stock price fell by -12.00% on the last day (Monday, 13th Jul 2026) from $0.0388 to $0.0341. During the last trading day the stock fluctuated 26.49% from a day low at $0.0336 to a day high of $0.0425. The price has fallen in 6 of the last 10 days and is down by -23.3% for this period. Volume has increased on the last day by 303 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 314 thousand shares were bought and sold for approximately $10.72 thousand.

Given the current short-term trend, the stock is expected to rise 12.35% during the next 3 months and, with a 90% probability hold a price between $0.0383 and $0.0722 at the end of this 3-month period.

OTLC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oncotelic Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0394 and $0.0478. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -43.87%. Further fall is indicated until a new bottom pivot has been found. Oncotelic Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Oncotelic Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0089 between high and low, or 26.49%. For the last week, the stock has had daily average volatility of 18.96%.

Oncotelic Therapeutics, Inc. is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OTLC) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Oncotelic Therapeutics, Inc. to open at $0.0367, and during the day (based on 14 day Average True Range), to move between $0.0313 and $0.0370, which gives a possible trading interval of +/-$0.0057 (+/-18.21%) up or down from last closing price. If Oncotelic Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 18.21% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0380, some $0.0039 (11.34%) from the current price of $0.0341, our system finds the risk reward not very attractive.

Is Oncotelic Therapeutics, Inc. stock A Buy?

The Oncotelic Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Oncotelic Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.025 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.0367 ( 7.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OTLC Performance

Trading levels for OTLC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0456 33.73%
R2 0.0422 23.77%
R1 0.0401 17.62%
Price 0.0341
S1 0.0333 -2.30%
S2 0.0312 -8.46%
S3 0.0278 -18.42%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0410 20.13%
R2 0.0395 15.73%
R1 0.0380 11.34%
Price 0.0341
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Oncotelic Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Oncotelic Therapeutics, Inc. is OTLC and it is traded on the PINK (Pink Sheets).

Should I buy or sell Oncotelic Therapeutics, Inc. Stock?
The Oncotelic Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Oncotelic Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Oncotelic Therapeutics, Inc. Stock?
Oncotelic Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oncotelic Therapeutics, Inc. Stock.

What's the current price of Oncotelic Therapeutics, Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Oncotelic Therapeutics, Inc. (OTLC) share was $0.0341.

What is the 52-week high and low for Oncotelic Therapeutics, Inc. Stock?
The 52-week high for Oncotelic Therapeutics, Inc. Stock is $0.110 and the 52-week low is $0.0300.

What is the market capitalization of Oncotelic Therapeutics, Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Oncotelic Therapeutics, Inc. is 15.141M.

When is the next earnings date for Oncotelic Therapeutics, Inc.?
The upcoming earnings date for Oncotelic Therapeutics, Inc. is Aug 24, 2026.
Click to get the best stock tips daily for free!
ABOUT ONCOTELIC THERAPEUTICS, INC.
Oncotelic Therapeutics
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops O...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE